APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Intelligence Drug Discovery Platform Market Analysis and Forecast 2026-2032

Report ID 174069810215 April 2026219 pages

Choose your research edition.

Industry ResearchArtificial Intelligence Drug Discovery Platform Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence Drug Discovery Platform Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence Drug Discovery Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence Drug Discovery Platform Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Artificial Intelligence Drug Discovery Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence Drug Discovery Platform include BenevolentAI, Schrödinger, Numerion Labs, XtalPi, Tencent, NVIDIA, Insilico Medicine, Iambic Therapeutics and insitro, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence Drug Discovery Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence Drug Discovery Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence Drug Discovery Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence Drug Discovery Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence Drug Discovery Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence Drug Discovery Platform revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence Drug Discovery Platform Segment by Company

BenevolentAI

Schrödinger

Numerion Labs

XtalPi

Tencent

NVIDIA

Insilico Medicine

Iambic Therapeutics

insitro

Valo Health

Genesis

DeepCure

Nimbus Therapeutics

Absci

Owkin

Eli Lilly

Recursion

Artificial Intelligence Drug Discovery Platform Segment by Type

Small Molecule Platform

Biomacromolecule Platform

Others

Artificial Intelligence Drug Discovery Platform Segment by Application

Pharmaceutical Companies

Research Institutions

Others

Artificial Intelligence Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence Drug Discovery Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence Drug Discovery Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence Drug Discovery Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Small Molecule Platform Major Player Table 3. Biomacromolecule Platform Major Player Table 4. Others Major Player Table 5. Global Artificial Intelligence Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Companies Major Player Table 7. Research Institutions Major Player Table 8. Others Major Player Table 9. Artificial Intelligence Drug Discovery Platform Industry Trends Table 10. Artificial Intelligence Drug Discovery Platform Industry Drivers Table 11. Artificial Intelligence Drug Discovery Platform Industry Opportunities and Challenges Table 12. Artificial Intelligence Drug Discovery Platform Industry Restraints Table 13. Global Artificial Intelligence Drug Discovery Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Artificial Intelligence Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Artificial Intelligence Drug Discovery Platform Market Share by Region (2021-2026) Table 16. Global Artificial Intelligence Drug Discovery Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Artificial Intelligence Drug Discovery Platform Market Share by Region (2027-2032) Table 18. Global Artificial Intelligence Drug Discovery Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Players (2021-2026) Table 20. Global Artificial Intelligence Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Artificial Intelligence Drug Discovery Platform Key Players Headquarters & Area Served Table 22. Global Artificial Intelligence Drug Discovery Platform Players, Product Type & Application Table 23. Global Artificial Intelligence Drug Discovery Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Artificial Intelligence Drug Discovery Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Artificial Intelligence Drug Discovery Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Type (2021-2026) Table 30. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Type (2027-2032) Table 31. Global Artificial Intelligence Drug Discovery Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Application (2021-2026) Table 35. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Application (2027-2032) Table 36. BenevolentAI Company Information Table 37. BenevolentAI Business Overview Table 38. BenevolentAI Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BenevolentAI Artificial Intelligence Drug Discovery Platform Product Portfolio Table 40. BenevolentAI Recent Development Table 41. Schrödinger Company Information Table 42. Schrödinger Business Overview Table 43. Schrödinger Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Schrödinger Artificial Intelligence Drug Discovery Platform Product Portfolio Table 45. Schrödinger Recent Development Table 46. Numerion Labs Company Information Table 47. Numerion Labs Business Overview Table 48. Numerion Labs Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Numerion Labs Artificial Intelligence Drug Discovery Platform Product Portfolio Table 50. Numerion Labs Recent Development Table 51. XtalPi Company Information Table 52. XtalPi Business Overview Table 53. XtalPi Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. XtalPi Artificial Intelligence Drug Discovery Platform Product Portfolio Table 55. XtalPi Recent Development Table 56. Tencent Company Information Table 57. Tencent Business Overview Table 58. Tencent Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Tencent Artificial Intelligence Drug Discovery Platform Product Portfolio Table 60. Tencent Recent Development Table 61. NVIDIA Company Information Table 62. NVIDIA Business Overview Table 63. NVIDIA Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. NVIDIA Artificial Intelligence Drug Discovery Platform Product Portfolio Table 65. NVIDIA Recent Development Table 66. Insilico Medicine Company Information Table 67. Insilico Medicine Business Overview Table 68. Insilico Medicine Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Insilico Medicine Artificial Intelligence Drug Discovery Platform Product Portfolio Table 70. Insilico Medicine Recent Development Table 71. Iambic Therapeutics Company Information Table 72. Iambic Therapeutics Business Overview Table 73. Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio Table 75. Iambic Therapeutics Recent Development Table 76. insitro Company Information Table 77. insitro Business Overview Table 78. insitro Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. insitro Artificial Intelligence Drug Discovery Platform Product Portfolio Table 80. insitro Recent Development Table 81. Valo Health Company Information Table 82. Valo Health Business Overview Table 83. Valo Health Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Valo Health Artificial Intelligence Drug Discovery Platform Product Portfolio Table 85. Valo Health Recent Development Table 86. Genesis Company Information Table 87. Genesis Business Overview Table 88. Genesis Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Genesis Artificial Intelligence Drug Discovery Platform Product Portfolio Table 90. Genesis Recent Development Table 91. DeepCure Company Information Table 92. DeepCure Business Overview Table 93. DeepCure Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. DeepCure Artificial Intelligence Drug Discovery Platform Product Portfolio Table 95. DeepCure Recent Development Table 96. Nimbus Therapeutics Company Information Table 97. Nimbus Therapeutics Business Overview Table 98. Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio Table 100. Nimbus Therapeutics Recent Development Table 101. Absci Company Information Table 102. Absci Business Overview Table 103. Absci Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Absci Artificial Intelligence Drug Discovery Platform Product Portfolio Table 105. Absci Recent Development Table 106. Owkin Company Information Table 107. Owkin Business Overview Table 108. Owkin Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Owkin Artificial Intelligence Drug Discovery Platform Product Portfolio Table 110. Owkin Recent Development Table 111. Eli Lilly Company Information Table 112. Eli Lilly Business Overview Table 113. Eli Lilly Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Eli Lilly Artificial Intelligence Drug Discovery Platform Product Portfolio Table 115. Eli Lilly Recent Development Table 116. Recursion Company Information Table 117. Recursion Business Overview Table 118. Recursion Artificial Intelligence Drug Discovery Platform Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Recursion Artificial Intelligence Drug Discovery Platform Product Portfolio Table 120. Recursion Recent Development Table 121. North America Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 127. North America Artificial Intelligence Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 135. China Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 136. China Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 137. China Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 138. China Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Artificial Intelligence Drug Discovery Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Artificial Intelligence Drug Discovery Platform Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia Artificial Intelligence Drug Discovery Platform Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Artificial Intelligence Drug Discovery Platform Image Figure 2. Global Artificial Intelligence Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Small Molecule Platform Image Figure 5. Biomacromolecule Platform Image Figure 6. Others Image Figure 7. Global Artificial Intelligence Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Artificial Intelligence Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Companies Image Figure 10. Research Institutions Image Figure 11. Others Image Figure 12. Global Artificial Intelligence Drug Discovery Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global Artificial Intelligence Drug Discovery Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Artificial Intelligence Drug Discovery Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Artificial Intelligence Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Artificial Intelligence Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Type (2021-2032) Figure 20. Global Artificial Intelligence Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Application (2021-2032) Figure 23. North America Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 25. North America Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 26. North America Artificial Intelligence Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 27. United States Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 32. Europe Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 33. Europe Artificial Intelligence Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 34. Germany Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 44. China Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 45. Asia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 47. Asia Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 48. Asia Artificial Intelligence Drug Discovery Platform Revenue Share by Region (2021-2032) Figure 49. Japan Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA Artificial Intelligence Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 59. Brazil Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Artificial Intelligence Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule Platform
  • Biomacromolecule Platform
  • Others
Applications
  • Pharmaceutical Companies
  • Research Institutions
  • Others
Companies covered
  • BenevolentAI
  • Schrödinger
  • Numerion Labs
  • XtalPi
  • Tencent
  • NVIDIA
  • Insilico Medicine
  • Iambic Therapeutics
  • insitro
  • Valo Health
  • Genesis
  • DeepCure
  • Nimbus Therapeutics
  • Absci
  • Owkin
  • Eli Lilly
  • Recursion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence Drug Discovery Platform Market by Type
  3. 1.2.1 Global Artificial Intelligence Drug Discovery Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Small Molecule Platform
  5. 1.2.3 Biomacromolecule Platform
  6. 1.2.4 Others
  7. 1.3 Artificial Intelligence Drug Discovery Platform Market by Application
  8. 1.3.1 Global Artificial Intelligence Drug Discovery Platform Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Companies
  10. 1.3.3 Research Institutions
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Artificial Intelligence Drug Discovery Platform Market Dynamics
  1. 2.1 Artificial Intelligence Drug Discovery Platform Industry Trends
  2. 2.2 Artificial Intelligence Drug Discovery Platform Industry Drivers
  3. 2.3 Artificial Intelligence Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence Drug Discovery Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence Drug Discovery Platform Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence Drug Discovery Platform Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence Drug Discovery Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence Drug Discovery Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence Drug Discovery Platform Revenue by Players
  2. 4.1.1 Global Artificial Intelligence Drug Discovery Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence Drug Discovery Platform Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence Drug Discovery Platform Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence Drug Discovery Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence Drug Discovery Platform Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence Drug Discovery Platform Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence Drug Discovery Platform Market Size by Type
  1. 5.1 Global Artificial Intelligence Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence Drug Discovery Platform Market Size by Application
  1. 6.1 Global Artificial Intelligence Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BenevolentAI
  2. 7.1.1 BenevolentAI Company Information
  3. 7.1.2 BenevolentAI Business Overview
  4. 7.1.3 BenevolentAI Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BenevolentAI Artificial Intelligence Drug Discovery Platform Product Portfolio
  6. 7.1.5 BenevolentAI Recent Developments
  7. 7.2 Schrödinger
  8. 7.2.1 Schrödinger Company Information
  9. 7.2.2 Schrödinger Business Overview
  10. 7.2.3 Schrödinger Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Schrödinger Artificial Intelligence Drug Discovery Platform Product Portfolio
  12. 7.2.5 Schrödinger Recent Developments
  13. 7.3 Numerion Labs
  14. 7.3.1 Numerion Labs Company Information
  15. 7.3.2 Numerion Labs Business Overview
  16. 7.3.3 Numerion Labs Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Numerion Labs Artificial Intelligence Drug Discovery Platform Product Portfolio
  18. 7.3.5 Numerion Labs Recent Developments
  19. 7.4 XtalPi
  20. 7.4.1 XtalPi Company Information
  21. 7.4.2 XtalPi Business Overview
  22. 7.4.3 XtalPi Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 XtalPi Artificial Intelligence Drug Discovery Platform Product Portfolio
  24. 7.4.5 XtalPi Recent Developments
  25. 7.5 Tencent
  26. 7.5.1 Tencent Company Information
  27. 7.5.2 Tencent Business Overview
  28. 7.5.3 Tencent Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tencent Artificial Intelligence Drug Discovery Platform Product Portfolio
  30. 7.5.5 Tencent Recent Developments
  31. 7.6 NVIDIA
  32. 7.6.1 NVIDIA Company Information
  33. 7.6.2 NVIDIA Business Overview
  34. 7.6.3 NVIDIA Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NVIDIA Artificial Intelligence Drug Discovery Platform Product Portfolio
  36. 7.6.5 NVIDIA Recent Developments
  37. 7.7 Insilico Medicine
  38. 7.7.1 Insilico Medicine Company Information
  39. 7.7.2 Insilico Medicine Business Overview
  40. 7.7.3 Insilico Medicine Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Insilico Medicine Artificial Intelligence Drug Discovery Platform Product Portfolio
  42. 7.7.5 Insilico Medicine Recent Developments
  43. 7.8 Iambic Therapeutics
  44. 7.8.1 Iambic Therapeutics Company Information
  45. 7.8.2 Iambic Therapeutics Business Overview
  46. 7.8.3 Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
  48. 7.8.5 Iambic Therapeutics Recent Developments
  49. 7.9 insitro
  50. 7.9.1 insitro Company Information
  51. 7.9.2 insitro Business Overview
  52. 7.9.3 insitro Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 insitro Artificial Intelligence Drug Discovery Platform Product Portfolio
  54. 7.9.5 insitro Recent Developments
  55. 7.10 Valo Health
  56. 7.10.1 Valo Health Company Information
  57. 7.10.2 Valo Health Business Overview
  58. 7.10.3 Valo Health Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Valo Health Artificial Intelligence Drug Discovery Platform Product Portfolio
  60. 7.10.5 Valo Health Recent Developments
  61. 7.11 Genesis
  62. 7.11.1 Genesis Company Information
  63. 7.11.2 Genesis Business Overview
  64. 7.11.3 Genesis Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Genesis Artificial Intelligence Drug Discovery Platform Product Portfolio
  66. 7.11.5 Genesis Recent Developments
  67. 7.12 DeepCure
  68. 7.12.1 DeepCure Company Information
  69. 7.12.2 DeepCure Business Overview
  70. 7.12.3 DeepCure Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 DeepCure Artificial Intelligence Drug Discovery Platform Product Portfolio
  72. 7.12.5 DeepCure Recent Developments
  73. 7.13 Nimbus Therapeutics
  74. 7.13.1 Nimbus Therapeutics Company Information
  75. 7.13.2 Nimbus Therapeutics Business Overview
  76. 7.13.3 Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
  78. 7.13.5 Nimbus Therapeutics Recent Developments
  79. 7.14 Absci
  80. 7.14.1 Absci Company Information
  81. 7.14.2 Absci Business Overview
  82. 7.14.3 Absci Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Absci Artificial Intelligence Drug Discovery Platform Product Portfolio
  84. 7.14.5 Absci Recent Developments
  85. 7.15 Owkin
  86. 7.15.1 Owkin Company Information
  87. 7.15.2 Owkin Business Overview
  88. 7.15.3 Owkin Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Owkin Artificial Intelligence Drug Discovery Platform Product Portfolio
  90. 7.15.5 Owkin Recent Developments
  91. 7.16 Eli Lilly
  92. 7.16.1 Eli Lilly Company Information
  93. 7.16.2 Eli Lilly Business Overview
  94. 7.16.3 Eli Lilly Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Eli Lilly Artificial Intelligence Drug Discovery Platform Product Portfolio
  96. 7.16.5 Eli Lilly Recent Developments
  97. 7.17 Recursion
  98. 7.17.1 Recursion Company Information
  99. 7.17.2 Recursion Business Overview
  100. 7.17.3 Recursion Artificial Intelligence Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Recursion Artificial Intelligence Drug Discovery Platform Product Portfolio
  102. 7.17.5 Recursion Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence Drug Discovery Platform Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence Drug Discovery Platform Revenue by Country
  11. 8.6.1 North America Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence Drug Discovery Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence Drug Discovery Platform Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence Drug Discovery Platform Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence Drug Discovery Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence Drug Discovery Platform Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence Drug Discovery Platform Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence Drug Discovery Platform Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence Drug Discovery Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence Drug Discovery Platform Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence Drug Discovery Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst